Trial
NCT03591874
Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Ocugen
Collaborators
—
Condition
Graft Versus Host Disease
Intervention
Brimonidine Tartrate
Why stopped
Primary endpoint was not met.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-06